Showing 1 - 19 results of 19 for search 'Nicholas Lintzeris', query time: 0.07s
Refine Results
-
1
-
2
-
3
Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study by Benjamin T. Trevitt, Sasha Bailey, Llewellyn Mills, Thomas R. Arkell, Anastasia Suraev, Iain S. McGregor, Nicholas Lintzeris
Published 2024-01-01
Article -
4
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder by Llewellyn Mills, Adrian Dunlop, Mark Montebello, Jan Copeland, Raimondo Bruno, Meryem Jefferies, Iain Mcgregor, Nicholas Lintzeris
Published 2022-10-01
Article -
5
Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review by Tristan Hurzeler, Joshua Watt, Warren Logge, Ellen Towers, Anastasia Suraev, Nicholas Lintzeris, Paul Haber, Kirsten C. Morley
Published 2024-03-01
Article -
6
-
7
-
8
Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022–2023 (CAMS-22) by Llewellyn Mills, Jonathon C. Arnold, Anastasia Suraev, Sarah V. Abelev, Cilla Zhou, Thomas R. Arkell, Iain S. McGregor, Nicholas Lintzeris
Published 2024-05-01
Article -
9
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic by Adrian Dunlop, Buddhima Lokuge, Debbie Masters, Marcia Sequeira, Peter Saul, Grace Dunlop, John Ryan, Michelle Hall, Nadine Ezard, Paul Haber, Nicholas Lintzeris, Lisa Maher
Published 2020-05-01
Article -
10
Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal. by Liam S Acheson, Nadine Ezard, Nicholas Lintzeris, Adrian Dunlop, Jonathan Brett, Craig Rodgers, Anthony Gill, Michael Christmass, Rebecca McKetin, Michael Farrell, Steve Shoptaw, Krista J Siefried
Published 2022-01-01
Article -
11
Evaluation of an Assertive Management and Integrated Care Service for Frequent Emergency Department Attenders with Substance Use Disorders: The Impact Project: Evaluating an assert... by Nicholas Lintzeris, Rachel M. Deacon, Marian Shanahan, James Clarke, Stephanie MacFarlane, Stefanie Leung, Michelle Schulz, Anthony Jackson, Daniel Khamoudes, David E. A. Gordon, Apo Demirkol
Published 2020-04-01
Article -
12
Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal by Liam S. Acheson, Nadine Ezard, Nicholas Lintzeris, Adrian Dunlop, Jonathan Brett, Craig Rodgers, Anthony Gill, Michael Christmass, Rebecca McKetin, Michael Farrell, Steve Shoptaw, Krista J. Siefried
Published 2022-01-01
Article -
13
Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study by Gabrielle Campbell, Firouzeh Noghrehchi, Suzanne Nielsen, Phillip Clare, Raimondo Bruno, Nicholas Lintzeris, Milton Cohen, Fiona Blyth, Wayne Hall, Briony Larance, Phillip Hungerford, Timothy Dobbins, Michael Farrell, Louisa Degenhardt
Published 2020-11-01
Article -
14
Trial protocol of an open-label pilot study of oral naltrexone–bupropion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial) by Jonathan Brett, Paul S Haber, Nicholas Lintzeris, Didier Jutras-Aswad, Nadine Ezard, Brendan Clifford, Krista J Siefried, Adrian John Dunlop, Liam Acheson, Carl Moller, Michael Christmass, Kirsten Morley, Steven Shoptaw, Madhukar H Trivedi
Published 2025-02-01
Article -
15
A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol by Anjali K. Bhardwaj, Llew Mills, Michael Doyle, Arshman Sahid, Mark Montebello, Lauren Monds, Shalini Arunogiri, Paul Haber, Valentina Lorenzetti, Dan I. Lubman, Peter Malouf, Mary E. Harrod, Adrian Dunlop, Tom Freeman, Nicholas Lintzeris
Published 2024-03-01
Article -
16
Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label stu... by Eugenia Oviedo-Joekes, John Strang, Nicholas Lintzeris, Carla Treloar, Craig Rodgers, Nadine Ezard, James Bell, Alison Ritter, Krista J Siefried, Darren Roberts, Adrian John Dunlop, Vendula Belackova, Marianne Jauncey, Maureen Steele, Willem van den Brink
Published 2024-08-01
Article -
17
Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol by Anjali K. Bhardwaj, David J. Allsop, Jan Copeland, Iain S. McGregor, Adrian Dunlop, Marian Shanahan, Raimondo Bruno, Nghi Phung, Mark Montebello, Craig Sadler, Jessica Gugusheff, Melissa Jackson, Jennifer Luksza, Nicholas Lintzeris, Agonist Replacement for Cannabis Dependence (ARCD) study group
Published 2018-05-01
Article -
18
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study by Adrian Dunlop, Louisa Degenhardt, Michael Farrell, Marian Shanahan, Suzanne Nielsen, Briony Larance, Kari Lancaster, Marianne Byrne, Nicholas Lintzeris, Jason Grebely, Jeyran Shahbazi, Gregory Dore, Robert Ali, Carla Treloar, Stella Nalukwago, Craig Rodgers, Michael McDonough, Jon Cook, Mark Montebello, Michael Aufgang, Robert Weiss, Zoe Griffin
Published 2020-07-01
Article -
19
Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study by Gabrielle Campbell, PhD, Wayne D Hall, PhD, Amy Peacock, PhD, Nicholas Lintzeris, MD, Raimondo Bruno, PhD, Briony Larance, PhD, Suzanne Nielsen, PhD, Milton Cohen, MD, Gary Chan, PhD, Richard P Mattick, PhD, Fiona Blyth, PhD, Marian Shanahan, PhD, Timothy Dobbins, PhD, Michael Farrell, MD, Louisa Degenhardt, PhD
Published 2018-07-01
Article